Structure (Methylphenidate 01)
Methylphenidate Hydrochloride
Product Images NDC 57664-609
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 57664-609). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Methylphenidate 02)
This text appears to be a medication label for Methylphenidate Hydrochloride Extended-Release Tablets. The tablets are available in 18 mg strength, and the recommended dosage is 5 mg three times a day. The rest of the text appears to be a graph or chart showing the plasma concentration of the medication over time. However, some of the characters in the graph are not readable, so it is difficult to provide a more specific description.*
Figure 2 (Methylphenidate 03)
This is a brief summary of a clinical trial investigating the effectiveness of Methylphenidate Hydrochloride Extended-Release tablets in treating inattention and overactivity. The trial involved three different stages, and the provided text only presents results from "Study 1" at "Week 4." There is also a chart showing the number of symptoms reported in the trial.*
Figure 3 (Methylphenidate 04)
Pdp-18mg (Methylphenidate 05)
Pdp-27mg (Methylphenidate 06)
Pdp-36mg (Methylphenidate 07)
Not available.*
Pdp-54mg (Methylphenidate 08)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
